Literature DB >> 9409438

Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease).

Y Hosoda1, E Ikeda, S Hirose.   

Abstract

Spontaneous occlusion of the circle of Willis (cerebrovascular Moyamoya disease; SOCW) was first described by Japanese surgeons and is thought to have a high incidence in the Japanese population. SOCW is characterized by the angiographical findings of the obstructive vascular lesions around the terminal portions of the internal carotid arteries and the formation of abnormal vascular networks visualized in the arterial phase without any definite underlying conditions. Here, we present a detailed histopathological observation of 31 autopsy cases with SOCW to discuss its etiology which is still a matter of dispute. The obstructive vascular lesion around the terminal portions of the internal carotid arteries which is thought to be the primary site affected in SOCW is due to multilayered eccentric intimal fibrous thickening suggestive of organized mural thrombi. In fact, we found thrombotic lesions frequently in the major cerebral arteries, including those of the circle of Willis, of autopsy cases with SOCW. This fact supports the idea that thrombi play an important role in establishment of the vascular lesions. Extracranial vessels are also shown to be involved and it is conceivable that the systemic etiologic factor, such as the systemic background to form thrombi, exists in patients with SOCW.

Entities:  

Mesh:

Year:  1997        PMID: 9409438     DOI: 10.1016/s0303-8467(97)00044-9

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  19 in total

1.  Comparative analysis of serum proteomes of moyamoya disease and normal controls.

Authors:  Eun-Jeong Koh; Han-Na Kim; Tian-Ze Ma; Ha-Young Choi; Yong-Geun Kwak
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

2.  Improved visualization of superficial temporal artery using segmented time-of-flight MR angiography with venous suppression at 7T.

Authors:  Ning Wei; Zihao Zhang; Jing An; Dehe Weng; Yan Zhuo
Journal:  Neuroradiology       Date:  2018-09-22       Impact factor: 2.804

3.  Histopathological features of middle cerebral artery and superficial temporal artery from patients with moyamoya disease and enlightenments on clinical treatment.

Authors:  Shou-Jia Sun; Jian-Jian Zhang; Zheng-Wei Li; Zhong-Wei Xiong; Xiao-Lin Wu; Sheng Wang; Kai Shu; Jin-Cao Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

4.  Assessment of the cortical artery using computed tomography angiography for bypass surgery in moyamoya disease.

Authors:  Hime Suzuki; Takeshi Mikami; Katsuya Komatsu; Shouhei Noshiro; Kei Miyata; Toru Hirano; Masahiko Wanibuchi; Nobuhiro Mikuni
Journal:  Neurosurg Rev       Date:  2016-07-30       Impact factor: 3.042

5.  Moyamoya disease and surgical intervention.

Authors:  Jay W Rhee; Suresh N Magge
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 6.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

7.  Arterio-embolic ischemic stroke in children with moyamoya disease.

Authors:  Peter Horn; Eva Bueltmann; Christoph V Buch; Peter Schmiedek
Journal:  Childs Nerv Syst       Date:  2004-05-18       Impact factor: 1.475

8.  Vessel Wall and Lumen Features in North American Moyamoya Patients.

Authors:  Petrice M Cogswell; Sarah K Lants; L Taylor Davis; Meher R Juttukonda; Matthew R Fusco; Manus J Donahue
Journal:  Clin Neuroradiol       Date:  2019-08-06       Impact factor: 3.649

9.  Clinical and immunopathological features of Moyamoya disease.

Authors:  Runhua Lin; Zeyu Xie; Jianfa Zhang; Hongwu Xu; Hang Su; Xuerui Tan; Dongping Tian; Min Su
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 10.  Cognitive Dysfunction Survey of the Japanese Patients with Moyamoya Disease (COSMO-JAPAN Study): study protocol.

Authors:  Yasushi Takagi; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.